IGF1 and fatty liver disease: The presence of insulin resistance and hepatic steatosis may support the hypothesis that diabetes promotes HCC, while the growth of insulin-like growth factor-1, the increase in leptin, the decrease in adiponectin and the imbalance of pro-inflammatory/anti-inflammatory cytokines are supported the appeal opinion [30].